Retractable Technologies (NYSE:RVP) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of Retractable Technologies (NYSE:RVP) in a research note issued to investors on Saturday morning. The brokerage issued a hold rating on the stock.

Retractable Technologies Stock Down 3.1 %

RVP stock opened at $0.62 on Friday. The stock has a fifty day moving average of $0.67 and a 200-day moving average of $0.89. Retractable Technologies has a fifty-two week low of $0.56 and a fifty-two week high of $1.34. The company has a market capitalization of $18.56 million, a price-to-earnings ratio of -1.15 and a beta of 1.98. The company has a debt-to-equity ratio of 0.01, a quick ratio of 5.92 and a current ratio of 8.57.

Institutional Investors Weigh In On Retractable Technologies

A hedge fund recently bought a new stake in Retractable Technologies stock. PFG Investments LLC bought a new position in Retractable Technologies, Inc. (NYSE:RVP) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned 0.12% of Retractable Technologies as of its most recent SEC filing. Hedge funds and other institutional investors own 7.58% of the company’s stock.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.